Multiple nonfunctional alleles of CCR5 are frequent in various human populations

Blood

Volumn 96, Issue 5, 2000, Pages 1638-1645

  Blanpain, C ^a   Lee, B ^a   Tackoen, M ^a   Puffer, B ^a   Boom, A ^a   Libert, F ^a   Sharron, M ^a   Wittamer, V ^a   Vassart, G ^a   Doms, R W ^a   Parmentier, M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 2; RANTES; VIRUS RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; BASE PAIRING; CELL SURFACE; GENETIC CODE; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; VIRUS RESISTANCE;

EID: 0034284489     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1638     Document Type: Article

References (58)

1. Chemokine receptors: Keys to AIDS pathogenesis?
2. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
3. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication
4. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells
5. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
6. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
7. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocytederived macrophages
8. Coreceptor/chemokine receptor expression on human hematopoietic cells: Biological implications for human immunodeficiency virus-type 1 infection
9. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia
10. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
11. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
12. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
13. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
14. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
15. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
16. CC chemokine receptor 5 polymorphism in rheumatoid arthritis
17. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
18. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-lalpha and IP-10 are expressed in demyelinating brain lesions
19. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis
20. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
21. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
22. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
23. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
24. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe
25. The extent of genetic variation in the CCR5 gene
26. Novel alleles of the chemokine-receptor gene CCR5
27. The second extracellular loop of CCR5 is the major determinant of ligand specificity
28. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses
29. SR alpha promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat
30. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor
31. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
32. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
33. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
34. HIV-l-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
35. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation
36. The dual nature of the tachykinin NK1 receptor
37. HIV and SIV gp120 binding does not predict coreceptor function
38. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
39. Multiple extracellular elements of CCR5 and HIV-1 entry; Dissociation from response to chemokines
40. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor
41. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
42. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
43. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1
44. Multiple charged and aromatic residues in CCR5 aminoterminal domain are involved in high affinity binding of both chemokines and HIV-1 env protein
45. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Coreceptor and ligand binding function
46. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes
47. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
48. Association of CCR5 delta32 with reduced risk of asthma
49. Genetic acceleration of AIDS progression by a promoter variant of CCR5
50. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
51. Chemokines and HIV replication
52. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines
53. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines
54. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells role of signal transduction
55. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
56. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
57. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
58. Apoptosis of CD8+ T coifs is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4